There is no success in today’s R&D world without in-depth therapeutic expertise to support Trial Execution, Consulting and Placement solutions.

We offer end-to-end study execution and consulting services across a broad spectrum of therapeutic areas, including oncology, immunology, CNS, vaccines, and rare diseases, among others. Our experience allows us to execute the most complex clinical trials and provide tailored solutions to pharma and biotech companies.

Our expertise in many therapeutic areas of preclinical and clinical research ensures that we move your molecule forward, whether through our preclinical, clinical, or bioanalytical service offerings. As a full development program or a stand-alone service, we apply our expertise in therapeutic areas to everything we do. We will help seamlessly transition your molecule through the phases of development in any of our therapeutic specialties, helping you get your drug to market faster.

Our experience in general toxicology, safety pharmacology, and clinical pharmacology spans a wide range of therapeutic specialties, both small and large molecules. Across the therapeutic areas of both preclinical and clinical research, we analyze numerous biomarkers, and are always adding new validated methods to our panels that cover preclinical and clinical matrices. Finally, we have extensive experience in designing and conducting proof-of-concept studies in healthy participants or patients.

Our team contains diverse therapeutic specialties and experience, retaining the most experience in clinical development in the following therapeutic areas:

Neurology

Musculoskeletal

Oncology/Hematology/Cell Therapy

Infectious Diseases

Respiratory

Endocrinology

Gastroenterology

Allergology

Cardiology

Beyond Oneiric’s in-house expertise, we have developed individual strategic partnerships with key academic paediatric centres to augment our existing pediatric expertise with insights from research-minded thought leaders. With our Paediatric Research Partners (PRP) located across pan India, we have an enhanced ability to design and deliver pediatric clinical trials more effectively and efficiently leading to an ability to offer novel treatment options to children of all ages.